HomeCHRS • NASDAQ
add
Coherus Oncology Inc
Previous close
$1.55
Day range
$1.54 - $1.61
Year range
$0.70 - $2.43
Market cap
181.90M USD
Avg Volume
1.08M
P/E ratio
1.01
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 10.25M | -0.41% |
Operating expense | 52.34M | 8.80% |
Net income | 297.77M | 2,404.52% |
Net profit margin | 2.90K | 2,413.87% |
Earnings per share | -0.34 | -142.86% |
EBITDA | -44.47M | -15.69% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 237.64M | 49.23% |
Total assets | 439.46M | -34.88% |
Total liabilities | 319.64M | -57.89% |
Total equity | 119.83M | — |
Shares outstanding | 116.23M | — |
Price to book | 1.50 | — |
Return on assets | -28.06% | — |
Return on capital | -82.14% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 297.77M | 2,404.52% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2010
Headquarters
Website
Employees
177
